Clinical Neuroscience

[Cholinesterase activity of subdural haematomas]

ÁFRA Dénes1, WOLLEMANN Mária1

AUGUST 01, 1963

Clinical Neuroscience - 1963;16(08)

[The authors report on cholinesterase enzyme activity assays of operated subdural and intracerebral haematoma specimens. By determining the cholinesterase and acetylcholinesterase activity of the fluid obtained at surgery, they attempted to draw parallels between enzyme activity and the time of haematoma persistence. The results showed that the fluid content of the capsular haematoma is not stable from the time of formation. The variation in the activity of the two enzymes studied suggests the possibility that the fluid content is continuously replenished, presumably by transudation.]

AFFILIATIONS

  1. Országos Idegsebészeti Tudományos Intézet

COMMENTS

0 comments

Further articles in this publication

Clinical Neuroscience

[Our experience with Parkazine and its combination with other antiparkinsonian medicines]

DOBI Sándor

[Following Klimes' positive experience with outpatients, we have also had positive experience with Parkazine in hospital, which is mostly more severe. We have experienced a pronounced antitremor effect and we have experienced what was definitely an advantage over other previous drugs, that it also has a significant antitremor effect. This anti-tremor effect, which is all the shorter the patient's anamnesis, is the main advantage of Parkazine and justifies its use in all cases of Parkinson's syndrome. In addition to its beneficial effects on tremor and rigor, it also significantly improves akinesia through rigor reduction, without affecting primary motor impulsion. The latter should be classified as psychic symptoms, which are not affected by parkazine. Nevertheless, it does have a significant secondary psychic effect, which can be attributed to an improvement in the ability of helpless tremor patients to move and a reduction in tremor, by which the emotional afficiability of patients is also reduced. To influence the autonomic phenomena, which are a sub-symptom of Parkinson's syndrome and which greatly impair social integration, the drug can be preferably combined with belladonna derivatives, in our experience most notably Bellafit. This implies, accepting the different localisation mechanisms of the main components of PD, that Parkazine targets the areas involved in the generation of PD tremor and rigorous tonicity. ]

Clinical Neuroscience

[Analysis of symptomatic epipharyngeal tumour cases with trigeminal neuralgia]

LUKÁCS Kornél

[After describing the cases of three patients with epipharyngeal tumours, I will summarise the symptomatology of epipharyngeal tumours, emphasising the so-called latent phase, when only the elevation of pain to organic status and the correct evaluation of the otological complaints can help to establish an early diagnosis.]

Clinical Neuroscience

[Spontaneous intracerebral haematomas surgical treatment]

ÁFRA Dénes, OROSZ Éva

[The authors report the results of surgical treatment of 28 spontaneous intracerebral haematomas. In 12 cases, the cause of the haemorrhage was hypertonic arteriosclerosis based on clinical investigations; in 2 juvenile patients the haemorrhage was due to a microangioma undetectable by angiography, while in the other cases the aetiology was unknown. The cases were classified into 3 groups according to onset and course : 1. pseudotumoral or chronic form, 2. apoplectiform onset and 3. subarachnoid haemorrhage. The distribution of haematomas according to localisation was as follows: frontal 5, temporal 8, capsular 5, trigonal 9, cerebellar 1. Of the 28 patients, 5 died (18% surgical mortality). Of the 10 patients operated on within two weeks, 4 died, and of the 18 operated on later, 1 died. Despite the strikingly better results of late surgery, categorical avoidance of early intervention is not possible, but requires individual assessment of the surgical indicatio, especially in acute fasciitis. ]

Clinical Neuroscience

[Nervous system of engine builders working on assembly lines]

BÁLINT István, HÓDOS Tibor

[By means of modern technology and organization of work, the effect of stress on the nervous system caused by factors outside the objective nature of the work process can be substantially reduced in the case of production on the production line. The success of the measures aimed at reducing the strain on the nervous system of people working on the production line can only be increased if the stress situation resulting from the nature of the work process is changed. Since the repetitive and uniform manipulations during the bound work process primarily require an adaptation of the individual tempo and rhythm within narrow limits, the nervous system load on the working person is reflected in the mental performance of the adaptation at the given moment of time. The investigations concerning time perception have shown the necessity of improving the working conditions in two areas with regard to the further reduction of the nervous system load: 1. in order to further limit monotony, the linking of the tasks on the production line must be regulated in a new way, 2. in order to facilitate time adaptation, more micro-breaks must be inserted between the individual tasks on the production line than before.]

All articles in the issue

Related contents

Clinical Neuroscience

Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias

BALÁZS Nóra , BERECZKI Dániel, KOVÁCS Tibor

In aging societies, the morbidity and mortality of dementia is increasing at a significant rate, thereby imposing burden on healthcare, economy and the society as well. Patients’ and caregivers’ quality of life and life expectancy are greatly determined by the early diagnosis and the initiation of available symptomatic treatments. Cholinesterase inhibitors and memantine have been the cornerstones of Alzheimer’s therapy for approximately two decades and over the years, more and more experience has been gained on their use in non-Alzheimer’s dementias too. The aim of our work was to provide a comprehensive summary about the use of cholinesterase inhibitors and memantine for the treatment of Alzheimer’s and non-Alzheimers’s dementias.

Clinical Neuroscience

Atypical presentation of late-onset Sandhoff disease: a case report

SALAMON András , SZPISJAK László , ZÁDORI Dénes, LÉNÁRT István, MARÓTI Zoltán, KALMÁR Tibor , BRIERLEY M. H. Charlotte, DEEGAN B. Patrick , KLIVÉNYI Péter

Sandhoff disease is a rare type of hereditary (autosomal recessive) GM2-gangliosidosis, which is caused by mutation of the HEXB gene. Disruption of the β subunit of the hexosaminidase (Hex) enzyme affects the function of both the Hex-A and Hex-B isoforms. The severity and the age of onset of the disease (infantile or classic; juvenile; adult) depends on the residual activity of the enzyme. The late-onset form is characterized by diverse symptomatology, comprising motor neuron disease, ataxia, tremor, dystonia, psychiatric symptoms and neuropathy. A 36-year-old female patient has been presenting progressive, symmetrical lower limb weakness for 9 years. Detailed neurological examination revealed mild symmetrical weakness in the hip flexors without the involvement of other muscle groups. The patellar reflex was decreased on both sides. Laboratory tests showed no relevant alteration and routine electroencephalography and brain MRI were normal. Nerve conduction studies and electromyography revealed alterations corresponding to sensory neuropathy. Muscle biopsy demonstrated signs of mild neurogenic lesion. Her younger brother (32-year-old) was observed with similar symptoms. Detailed genetic study detected a known pathogenic missense mutation and a 15,088 base pair long known pathogenic deletion in the HEXB gene (NM_000521.4:c.1417G>A; NM_000521:c.-376-5836_669+1473del; double heterozygous state). Segregation analysis and hexosaminidase enzyme assay of the family further confirmed the diagnosis of late-onset Sandhoff disease. The purpose of this case report is to draw attention to the significance of late-onset Sandhoff disease amongst disorders presenting with proximal predominant symmetric lower limb muscle weakness in adulthood.

Journal of Nursing Theory and Practice

[The Effect of Asthma Bronchiale on Everyday life Activities Among Adolescents]

RÁCZ Viktória Kinga, HEGEDŰS Bianka Ágnes , SZEBENI-KOVÁCS Gyula , FERENCZY Mónika

[The aim of this study is to assess the relationship between the physical activity of asthmatics, sleep disorders, the extent of asthma treatment, and to assess the quality of life in terms of physical activity. We conducted our quantitative, cross-sectional survey between 2020-2021. In a non-randomized, comfort sampling the target group was defined as adolescents aged between 14–18 years, their diagnosis of asthma bronchiale had to be for at least 1 year ago. The data were collected by a self-prepared questionnaire, the domains included: socio-demographic questions related to physical activites, symptoms, sleep disorders, severity of asthma. We used miniAQLQ to assess quality of life. The statistical analysis were performed by using Microsoft Excel 2016 and SPSS v 24 programs. Descriptive statistics (mean, standard deviation, minimum, maximum), two-sample t-test, Chi-square test were performed. The mean age of the respondents was 16±1.51, 38% were boys and 62% were girls (N=105). There was no significant difference between physical activity and the frequency of seizures and sleep disorders (p>0.05). There is a significant difference between the genders and the symptoms increasing with intense exercise (p=0.02). We found significant correlation between the active participations in physical education classes and the severity of the disease (p=0.021). There is a significant correlation between moderate-, social activities and physical activity (p<0.05). Appropriate health education, recommendation in career choices as well as in physical activities done by nurses may lead to decrease in the number of suffocation attacks in cases of adolescents suffering from asthma bronchiale.]

Clinical Neuroscience

To handle the HaNDL syndrome through a case: The syndrome of headache with neurologic deficits and cerebrospinal fluid lymphocytosis

ÇOBAN Eda, TEKER Ruken Serap, SERİNDAĞ Helin, SAKALLI Nazan, SOYSAL Aysun

The syndrome of headache with neurologic deficits and cerebrospinal fluid lymphocytosis (HaNDL) is a rare entity. This disease has been related to migrainous headaches. It is a benign, self-limited disorder, which is characterized by fluctuating neurological symptoms and cerebrospinal fluid lymphocytosis. We describe a case of a 47 years old man with acute onset of headache and aphasia. Cerebrospinal fluid analysis revealed a lymphocytic pleocytosis (25 cells/μl, 100% lymphocytes). Electroencephalogram showed moderate slow rhythm in the left hemisphere, with temporoparietal predominance, and without epileptiform activity. His blood tests as well as magnetic resonance imaging (MRI) results were normal. With the diagnosis of HaNDL syndrome the patient was accepted in the Department of Neurology and discharged with full recovery.

Clinical Neuroscience

[Controversies in neurology: Diagnosis, follow up and therapy of multiple sclerosis with pathomechanismal approach]

VÉCSEI László

[The clinical boundaries between the relapsing and progressive course of multiple sclerosis are often indistinct. Despite the variable patterns of evolution, there are no biological reasons for discerning different multiple sclerosis phenotypes. Indeed, both primary progressive and secondary forms of the disease share similar pathological features in respect of the extent of inflammatory infiltrates, axonal damage, and cortical demyelination. The data indicating that primary progressive multiple sclerosis is preceded by an asymptomatic relapsing remitting phase. The proposed definition of secondary progressive multiple slcerosis, the attainment of at least EDSS of 4 is required to mark the transition to the progressive phase. Therefore, the clinical progress can be uncovered in the early phase of the disease. Furthermore, a continuous progression independent of relapsing activity is commonly observed during the relapsing remitting phase. A continuous smouldering process underpins the subtle clinical deterioration, which stands out as an important unmet treatment target. Concerning cognitive dysfunction of the patients pro-inflammatory cytokines have been associated with worse cognition in active multiple sclerosis, and this inflammatory milieu could also contribute to altered mentation during relapses. Therefore, long before people with multiple sclerosis become physically disabled, they have usually acquired hidden disabilities related to cognitive impairment. Silent progression appears during the relapsing remitting phase and it associates with brain atrophy. This suggests that the same process that underlies secondary progressive multiple sclerosis likely begins far earlier than is generally recognized. This supports a unitary view of multiple sclerosis biology. ]